Publication | Closed Access

Pharmacokinetics, Pharmacodynamics and Safety of Febuxostat, a Non-Purine Selective Inhibitor of Xanthine Oxidase, in a Dose Escalation Study in Healthy Subjects

Healthy SubjectsPharmacological StudyPharmacologyXanthine OxidasePharmacotherapyDose Escalation StudyMedicinePharmacokineticsOxidative Stress